Takao H, Saji S, Sugiyama Y, Tachibana S, Goshima H, Kunii Y, Sakata K
Second Department of Surgery Gifu University School of Medicine, Japan.
Nihon Geka Gakkai Zasshi. 1988 Jul;89(7):992-8.
Fundamental studies were performed on adoptive immunotherapy, especially on effects on lymphocytic cytotoxic activity, of nonspecific immunosuppressive factors (ferritin, IAP, AFP) and of serum factors obtained from gastric cancer patients, and possible intervention of suppressor T cells in serum immunosuppressive activity on the cytotoxicity was also examined. The following results were obtained. 1) Cytotoxicity of LAK cells induced by culturing normal peripheral blood lymphocytes (PBL) with R-IL2 in the medium containing normal AB-type sera, was higher than that of PBL. 2) Effect of nonspecific immunosuppressive factors on cytotoxicity of LAK cells was lower than that on cytotoxicity of PBL. 3) Cytotoxicity of PBL was inhibited in a relatively specific fashion by sera from patients of the cancers which were of identical histological types with the target tumor cells, while that of LAK cells was hardly inhibited by patients' sera. 4) Cytotoxicity of Leu 15-PBL was inhibited by nonspecific immunosuppressive factors and also by cancer patients' sera in a relatively specific fashion in relation to histology. 5) Cytotoxicity of Leu 15-LAK cells was hardly inhibited by serum nonspecific and specific immunosuppressive factors. The above results showed that serum immunosuppressive factors might act on PBL cytotoxicity without intervention of suppressor T cells, and that LAK cells were hardly inhibited by such immunosuppressive factors. All these results suggested usefulness of adoptive immunotherapy with LAK.
对过继性免疫疗法进行了基础研究,特别是关于非特异性免疫抑制因子(铁蛋白、IAP、AFP)以及胃癌患者血清因子对淋巴细胞细胞毒性活性的影响,并研究了抑制性T细胞对血清免疫抑制活性在细胞毒性方面可能的干预作用。获得了以下结果。1)在含有正常AB型血清的培养基中,用R-IL2培养正常外周血淋巴细胞(PBL)诱导产生的LAK细胞的细胞毒性高于PBL。2)非特异性免疫抑制因子对LAK细胞细胞毒性的影响低于对PBL细胞毒性的影响。3)与靶肿瘤细胞组织学类型相同的癌症患者的血清以相对特异的方式抑制PBL的细胞毒性,而LAK细胞的细胞毒性几乎不受患者血清抑制。4)Leu 15-PBL的细胞毒性受到非特异性免疫抑制因子以及癌症患者血清的抑制,且与组织学相关,呈相对特异的方式。5)血清非特异性和特异性免疫抑制因子几乎不抑制Leu 15-LAK细胞的细胞毒性。上述结果表明,血清免疫抑制因子可能在无抑制性T细胞干预的情况下作用于PBL的细胞毒性,且LAK细胞几乎不受此类免疫抑制因子的抑制。所有这些结果提示LAK过继性免疫疗法的有效性。